Association between low-density lipoprotein composition and its metabolism in non-insulin-dependent diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 118-124

  Deegan, Patrick ^a   Owens, Daphne ^a   Collins, Patrick ^a   Johnson, Alan ^a   Tomkin, Gerald H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROMA; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GLYCOSYLATION; HUMAN; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032954557     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90020-3     Document Type: Article

References (45)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham Study. JAMA 241:2035-2038, 1979
2. Consensus Statement: Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 16:72-78, 1993
3. Stamler J: Multiple Risk Factor Intervention Trial (MRFIT). Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 16:434-444, 1993
4. Lahdenpera S, Sane T, Vuorinen-Markkola H, et al: LDL particle size in mildly hypertriglyceridaemic subjects: No relation to insulin resistance or diabetes. Atherosclerosis 113:227-236, 1995
5. Lahdenpera S, Syvanne M, Kahri J, et al: Regulation of low density lipoprotein particle size distribution in NIDDM and coronary disease: Importance of serum triglycerides. Diabetologia 39:453-461, 1996
6. Grey RS, Robins DC, Wang W, et al: Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler Thromb Vasc Biol 17:2713-2720, 1997
7. Caslake MJ, Packard CJ, Series JJ, et al: Plasma triglyceride and low density lipoprotein metabolism. Eur J Clin Invest 22:96-104, 1992
8. Caslake MJ, Packard CJ, Gaw A, et al: Fenofibrate and LDL metabolic heterogeneity in hypercholesterolaemia. Arterioscler Thromb 13:702-711, 1993
9. Kissebah AH, Alfarsi S, Evans DJ, et al: Plasma low density lipoprotein transport kinetics in non-insulin-dependent diabetes mellitus. J Clin Invest 71:655-667, 1983
10. Howard BV, Abbott WG, Beltz WF, et al: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 9:870-877, 1987
11. Taskinen M-R, Packard CJ, Shepherd J: Effect of insulin therapy on the metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39:1017-1027, 1990
12. Owens D, Maher V, Collins P, et al: Cellular cholesterol regulation - A defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologia 33:93-99, 1990
13. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-840, 1994
14. Dimitriadis E, Griffin M, Owens D, et al: Oxidation of low density lipoprotein in NIDDM: Its relationship to fatty acid composition. Diabetologia 38:1300-1306, 1995
15. Dimitriadis E, Griffin M, Owens D, et al: Lipoprotein composition in NIDDM. The effect of dietary oleic acid on composition and oxidisability and function of low and high density lipoproteins. Diabetologia 39:667-676, 1996
16. Owens D, McBrinn S, Collins P, et al: The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: A comparison in diabetic and non-diabetic subjects. Acta Diabetol 30:214-219, 1993
17. Griffin M, Dimitriadis E, Lenehan K, et al: Dietary monounsaturated fatty acids alter low density lipoprotein composition and function in type 2 diabetes mellitus. Q J Med 89:211-216, 1996
18. Dimitriadis E, Owens D, Johnson A, et al: Macrophage cholesterol accumulation and low density lipoprotein fatty acid composition in non-insulin-dependent diabetes. Diabet Med 13:54, 1996 (abstr)
19. Lopes-Virella M, Klein RL, Lyons TJ, et al: Glycosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37:550-557, 1988
20. Burnett JR, Wilcox LJ, Telford DE, et al: Inhibition of HMG-CoA reductase by Atorvastatin decreases both VLDL and LDL apolipo-protein B production in miniature pigs. Arterioscler Thromb Vasc Biol 17:2589-2600, 1997
21. Gaw A, Packard CJ, Murray EF, et al: Effects of simvastatin on apo B metabolism and LDL subfraction distribution. Arterioscler Thromb 13:170-189, 1993
22. Pyorala K, Pedersen TR, Kjekshus J, et al: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20:614-620, 1997
23. Lindgren FT, Jensen LC, Hatch FT: Isolation and analysis of serum lipoproteins, in Nelson GI (ed): Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. New York, NY, Wiley-Interscience, 1972, pp 221-245
24. Holmquist R: Surface modification of Beckman ultra-clear centrifuge tubes for density gradient centrifugation of lipoproteins. J Lipid Res 23:1249-1252, 1982
25. Bilheimer DW, Eisenberg S, Levi RI: The metabolism of low density lipoproteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 260:212-217, 1972
26. McFarlane AS: Efficient trace-labelling of proteins with iodine. Nature 182:53-56, 1958
27. 131I]-labelled plasma proteins. Phys Med Biol 2:36-53, 1957
28. Havel RA, Eder HM, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
29. Markwell MAK, Haas SM, Bieber LL, et al: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210, 1978
30. Jack CM, Sheridan B, Kennedy L, et al: Non-enzymatic glycosylation of low density lipoproteins. Results of an affinity chromatography method. Diabetologia 31:126-128, 1988
31. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
32. Sattler W, Puhl H, Kostner GM, et al: Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/methanol transesterification of lyophilised samples instead of Folch extraction gives higher yields. Anal Biochem 198:184-190, 1991
33. Griffin M, McInerny D, Collins P, et al: Autoantibodies to oxidised LDL are related to LDL fatty acid composition in diabetes. Diabet Med 14:741-747, 1997
34. Owens D, Stinson J, Collins P, et al: Improved regulation of cellular cholesterologenesis in diabetes: An effect of reduction in serum cholesterol. Diabet Med 8:151-156, 1991
35. Malmendeier C, Delcroix C, Lontie J-F: Kinetics of a heterogeneous population of particles in low density lipoprotein apolipoprotein B. Atherosclerosis 108:137-148, 1994
36. Packard CJ, Gaw A, Demant T, et al: Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J Lipid Res 36:172-187, 1995
37. Gylling H, Miettinen TA: Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care 20:90-95, 1997
38. Egusa G, Beltz WF, Grundy SM, et al: Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest 76:596-603, 1985
39. Kissebah AH, Alfarsi S, Evans DJ, et al: Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31:217-225, 1982
40. Gylling H, Miettinen TA: Serum cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37:773-780, 1994
41. Mazzone T, Foster D, Chait A: In vivo stimulation of low density lipoprotein degradation by insulin. Diabetes 33:333-338, 1984
42. Kortlandt W, Benschop C, van Rijn HJM, et al: Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia 35:202-207, 1992
43. Owens D, Deegan P, Collins P, et al: Glycosylated low density lipoprotein - Mechanism of binding to endothelial cells and macrophages. Atherosclerosis 112:266, 1995 (abstr)
44. Kleinveld HA, Demacker PN, DeHaan AF, et al: Decreased in vitro oxidisability of low density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Eur J Clin Invest 23:189-295, 1993
45. Bredie SJ, deBruin TW, Demacker PN, et al: Comparison of gemfibrozil verus simvastatin in familial combined hyperlipidaemia and effects on apolipoprotein-B-containing lipoproteins, low density lipoprotein subfraction profile and low density lipoprotein oxidisability. Am J Cardiol 75:348-353, 1995